A compounded form of imiquimod, a topical immune response modifier, showed promise as a treatment for ocular surface malignancies in a small case series. The drug appeared fairly safe, although with a ...
3 Anatomical Pathology Department, Miguel Servet University Hospital, Zaragoza, Spain Correspondence to Dr Elena Garcia-Martin, Hospital Universitario Miguel Servet, Consultas Externas de Oftalmología ...
Case series showed 5 percent ointment may be safe and effective for diffuse conjunctival melanoma in situ or ocular surface squamous neoplasia ...
† Center for Drug Design, University of Minnesota, 516 Delaware Street SE, Minneapolis, Minnesota 55455, United States Article Views are the COUNTER-compliant sum of full text article downloads since ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback